drugset / Trial / NCT06328504

Efficacy of Cashew Nut Protein Immunotherapy

NCT06328504 ↗

Recruiting 39 enrolled Medical University of Warsaw
RandomizedParallel-groupOpen-labelTreatment

Summary

It is a randomized, single-center, controlled trial to evaluate the effectiveness of oral immunotherapy with cashew protein compared with standard treatment (elimination diet) in pediatric patients with cashew allergy.

Timeline

Start
2024-03-28
Primary completion
2026-04-21
Completion
2027-04-21

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject cashew protein Protein / enzyme biologic 1200 mg Oral

Indications